Edition:
United States

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

1,338.35INR
28 Apr 2017
Change (% chg)

Rs2.15 (+0.16%)
Prev Close
Rs1,336.20
Open
Rs1,340.00
Day's High
Rs1,372.00
Day's Low
Rs1,318.70
Volume
2,257,402
Avg. Vol
839,001
52-wk High
Rs1,750.00
52-wk Low
Rs1,318.70

Latest Key Developments (Source: Significant Developments)

Lupin says Goa plant gets three 483 observations by USFDA
Friday, 28 Apr 2017 06:13am EDT 

April 28 (Reuters) - Lupin Ltd :Lupin clarifies on news item, "Lupin's Goa plant receives adverse FDA observations"..Lupin clarifies that USFDA issued form 483 citing 3 observations.  Full Article

Lupin gets FDA approval for hypertension treating drug
Friday, 28 Apr 2017 05:09am EDT 

April 28 (Reuters) - Lupin Ltd :Says Lupin receives FDA approval for generic benicar tablets.Says drug used for treatment of hypertension.  Full Article

Lupin launches generic Epzicom tablets in U.S.
Wednesday, 29 Mar 2017 03:11am EDT 

Lupin Ltd : Says Lupin launches generic Epzicom tablets in the U.S. . Says drug indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection .Lupin's Abacavir and Lamivudine tablets, 600 mg/300 mg are ab rated generic equivalent of Viiv Healthcare Company's Epzicom tablets, 600 mg/300 mg..  Full Article

Lupin launches its pain drug in the U.S.
Wednesday, 8 Mar 2017 11:56pm EST 

Lupin Ltd : Says Lupin launches hydrocodone bitartrate and acetaminophen tablets in the U.S. .Says drug used for the relief of moderate to moderately severe pain.  Full Article

Lupin launches generic drug to treat major depressive disorder
Tuesday, 7 Mar 2017 01:06am EST 

Lupin Ltd : Says Lupin launches generic Paxil CR tablets in the U.S. .Drug indicated to treat major depressive disorder, panic disorder, social anxiety disorder and premenstrual dysphoric disorder.  Full Article

Lupin announces U.S. launch of generic drug to treat depression
Thursday, 2 Mar 2017 01:46am EST 

Lupin Ltd : Says Lupin launches generic Pristiq tablets in the U.S. .Says tablets are indicated for the treatment of major depressive disorder.  Full Article

Lupin receives USFDA approval for pain relievers
Tuesday, 28 Feb 2017 01:07am EST 

Lupin Ltd : Received final approval for its Oxycodone and Acetaminophen tablets USP, 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg from USFDA . Says Lupin shall commence promoting the product shortly .Oxycodone and Acetaminophen tablets USP, are indicated for relief of moderate to moderately severe pain.  Full Article

Lupin's unit Kyowa and Astellas enter into agreement
Monday, 27 Feb 2017 01:17am EST 

Lupin Ltd : Says Astellas and Lupin s subsidiary Kyowa enter into an agreement . Says deal gives Kyowa the exclusive right to distribute and promote extended-release tablets of quetiapine fumarate in Japan .When astellas gets approval for new drug application of extended-release tablets of quetiapine fumarate, Kyowa will exclusively distribute products in Japan.  Full Article

Lupin gets FDA nod for generic version of Bayer Healthcare's antibiotic drug
Thursday, 16 Feb 2017 05:01am EST 

Lupin Ltd :Says gets final fda nod for moxifloxacin hydrochloride tablets.  Full Article

Lupin gets FDA nod for hydrocodone bitartrate and homatropine methylbromide syrup
Thursday, 16 Feb 2017 04:58am EST 

Lupin Ltd :Says received USFDA approval for ANDA hydrocodone bitartrate and homatropine methylbromide oral solution (syrup).  Full Article

More From Around the Web

BRIEF-Lupin says Goa plant gets three 483 observations by USFDA

* Lupin clarifies on news item, "Lupin's Goa plant receives adverse FDA observations".